1
MI
New
Prenatal treatment of congenital adrenal hyperplasia. The United States experience
Endocrinol Metab Clin North Am
30
1
2001
1
13
2
MG
Forest
H
Betuel
M
David
Prenatal treatment in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: up-date 88 of the French multicentric study
Endocr Res
15
1–2
1989
277
301
3
MG
Forest
HG
Dörr
ESPE obo
Prenatal therapy in congenital adrenal hyperplasia due to 21-hydroxylase-deficiency: retrospective followup study of 253 treated pregnancies in 215 families
The Endocrinologist
13
2003
252
259
4
MI
New
A
Carlson
J
Obeid
Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies
J Clin Endocrinol Metab
86
12
2001
5.651
5.657
5
SA
Wudy
J
Homoki
WM
Teller
Successful prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Eur J Pediatr
153
8
1994
556
559
6
PW
Speiser
R
Azziz
LS
Baskin
A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency
Int J Pediatr Endocrinol
494173
2010
2010
7
S
Lajic
A
Nordenstrom
EM
Ritzen
A
Wedell
Prenatal treatment of congenital adrenal hyperplasia
Eur J Endocrinol Nov; 151 Suppl
3
2004
U63
U69
8
V
Tardy-Guidollet
R
Menassa
JM
Costa
New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002–2011)
J Clin Endocrinol Metab
99
4
2014
1.180
1.188
9
MI
New
YK
Tong
T
Yuen
Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma
J Clin Endocrinol Metab
99
6
2014
E1.022
E1.030
10
ND
Avent
LS
Chitty
Non-invasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound
Prenat Diagn
26
7
2006
598
603
11
C
Meaney
G
Norbury
Non-invasive prenatal diagnosis
Methods Mol Biol
688
2011
155
172
12
JC
Beck
JW
Johnson
Maternal administration of glucocorticoids
Clin Obstet Gynecol
23
1
1980
93
113
13
PW
Speiser
Prenatal treatment of congenital adrenal hyperplasia
J Urol
162
2
1999
534
536
14
HL
Claahsen-van der Grinten
NM
Stikkelbroeck
BJ
Otten
AR
Hermus
Congenital adrenal hyperplasia – pharmacologic interventions from the prenatal phase to adulthood
Pharmacol Ther
132
1
2011
1
14
15
MA
Coleman
JW
Honour
Reduced maternal dexamethasone dosage for the prenatal treatment of congenital adrenal hyperplasia
BJOG
111
2
2004
176
178
16
HG
Dorr
WG
Sippell
RP
Willig
[Prenatal diagnosis and therapy of adrenogenital syndrome with 21-hydroxylase deficiency]
Geburtshilfe Frauenheilkd
52
10
1992
586
588
17
MG
Forest
M
David
Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a 10 year experience
Indian J Pediatr
59
4
1992
515
522
18
MI
New
Vindication of prenatal diagnosis and treatment of congenital adrenal hyperplasia with low-dose dexamethasone
Am J Bioeth
10
12
2010
67
68
19
S
Nimkarn
MI
New
Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
Nat Clin Pract Endocrinol Metab
3
5
2007
405
413
20
S
Nimkarn
MI
New
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: A paradigm for prenatal diagnosis and treatment
Ann N Y Acad Sci
1192
1
2010
5
11
21
T
Hirvikoski
A
Nordenstrom
A
Wedell
M
Ritzen
S
Lajic
Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint
J Clin Endocrinol Metab
97
6
2012
1.881
1.883
22
WL
Miller
SF
Witchel
Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits
Am J Obstet Gynecol
208
5
2013
354
359
23
AB
Mercado
RC
Wilson
KC
Cheng
JQ
Wei
MI
New
Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency
J Clin Endocrinol Metab
80
7
1995
2.014
2.020
24
MI
New
Prenatal treatment of congenital adrenal hyperplasia: author differs with technical report
Pediatrics
107
4
2001
804
25
MI
New
M
Abraham
T
Yuen
O
Lekarev
An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia
Semin Reprod Med
30
5
2012
396
399
26
S
Lajic
A
Nordenstrom
T
Hirvikoski
Long-term outcome of prenatal treatment of congenital adrenal hyperplasia
Endocr Dev
13
2008
82
98
27
PD
Trautman
HF
Meyer-Bahlburg
J
Postelnek
MI
New
Mothers’ reactions to prenatal diagnostic procedures and dexamethasone treatment of congenital adrenal hyperplasia
J Psychosom Obstet Gynaecol
17
3
1996
175
181
28
S
Lajic
A
Wedell
TH
Bui
EM
Ritzen
M
Holst
Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia
J Clin Endocrinol Metab
83
11
1998
3.872
3.880
29
HF
Meyer-Bahlburg
C
Dolezal
SW
Baker
AD
Carlson
JS
Obeid
MI
New
Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone
J Clin Endocrinol Metab
89
2
2004
610
614
30
HF
Meyer-Bahlburg
C
Dolezal
SW
Baker
AD
Carlson
JS
Obeid
MI
New
Prenatal androgenization affects gender-related behavior but not gender identity in 5–12-year-old girls with congenital adrenal hyperplasia
Arch Sex Behav
33
2
2004
97
104
31
T
Hirvikoski
A
Nordenstrom
T
Lindholm
Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone
J Clin Endocrinol Metab
92
2
2007
542
548
32
M
Merce Fernandez-Balsells
K
Muthusamy
G
Smushkin
Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses
Clin Endocrinol (Oxf)
73
4
2010
436
444
33
HF
Meyer-Bahlburg
C
Dolezal
R
Haggerty
M
Silverman
MI
New
Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Eur J Endocrinol
167
1
2012
103
110
34
A
Maryniak
M
Ginalska-Malinowska
A
Bielawska
A
Ondruch
Cognitive and social function in girls with congenital adrenal hyperplasia – Influence of prenatally administered dexamethasone
Child Neuropsychol
20
1
2014
60
70
35
B
Khulan
AJ
Drake
Glucocorticoids as mediators of developmental programming effects
Best Pract Res Clin Endocrinol Metab
26
5
2012
689
700
36
Extract from the Norwegian National Report on Physical Activity and Health
Scand J Med Sci Sports
11
4
2001
255
257
37
JR
Seckl
Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms
Mol Cell Endocrinol
185
1–2
2001
61
71
38
JR
Seckl
WL
Miller
How safe is long-term prenatal glucocorticoid treatment?
JAMA
277
13
1997
1.077
1.079
39
A
de Vries
MC
Holmes
A
Heijnis
Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function
J Clin Invest
117
4
2007
1.058
1.067
40
AA
Vos
HW
Bruinse
Congenital adrenal hyperplasia: do the benefits of prenatal treatment defeat the risks?
Obstet Gynecol Surv
65
3
2010
196
205